- Home
- CYRX
CYRX
CryoPort Inc.
as 11-07-2024 4:00pm EST
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | BRENTWOOD |
| Market Cap: | 405.4M | IPO Year: | N/A |
| Target Price: | $12.83 | AVG Volume (30 days): | 346.4K |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.68 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.32 - $20.11 | Next Earning Date: | 11-07-2024 |
| Revenue: | $225,606,000 | Revenue Growth: | -6.26% |
| Revenue Growth (this year): | 1% | Revenue Growth (next year): | 8.87% |
Stock Insider Trading Activity of CryoPort Inc. (CYRX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Hariri Robert J | CYRX | Director | Aug 19 '24 | Sell | $9.47 | 1,000 | $9,465.00 | 23,061 | |
| Hariri Robert J | CYRX | Director | Aug 14 '24 | Sell | $8.70 | 2,000 | $17,395.40 | 23,061 |
Latest CryoPort Inc. News
CYRX Breaking Stock News: Dive into CYRX Ticker-Specific Updates for Smart Investing
Zacks
14 hours ago
CryoPort, Inc. (CYRX) Reports Q3 Loss, Misses Revenue Estimates
PR Newswire
15 hours ago
Cryoport Reports Third Quarter 2024 Financial Results
GuruFocus.com
2 days ago
CryoPort Inc (CYRX) Q3 2024: Everything You Need to Know Ahead of Earnings
Zacks
8 days ago
CryoPort, Inc. (CYRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
PR Newswire
10 days ago
Cryoport to Report Third Quarter 2024 Financial Results on November 7, 2024
PR Newswire
17 days ago
Cryoport and Gulf Coast Regional Blood Center Launch Strategic Alliance to Enhance Cellular Therapy Services
PR Newswire
18 days ago
TMRW Life Sciences and Cryoport Systems Form Strategic Partnership to Elevate Standards for Frozen Egg, Embryo, and Sperm Offsite Storage and Biologistics
MT Newswires
21 days ago
UBS Adjusts CryoPort Price Target to $9 From $7, Maintains Neutral Rating
Compare CYRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CYRX CryoPort Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.